Flutemetamol

CHEMBL579205 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

274.3 g/mol

LogP

3.8

Phase

4

This compound selectively binds to amyloid beta aggregates in brain tissue, used as part of PET imaging evaluation for Alzheimer's disease.

Moleküler Ağırlık

274,3200 g/mol

LogP

3,80

TPSA

73,40 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Alzheimer's Disease Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F

InChI

InChI=1S/C14H11FN2OS/c1-16-11-4-2-8(6-10(11)15)14-17-12-5-3-9(18)7-13(12)19-14/h2-7,16,18H,1H3

Molecular Formula

C14H11FN2OS

HBD / HBA

2 / 5

Döndürülebilir Bağlar

2

Ağır Atomlar

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This compound selectively binds to amyloid beta aggregates in brain tissue, used as part of PET imaging evaluation for Alzheimer's disease.

Yes, Flutemetamol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL579205. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 10107393. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Flutemetamol PillFYI'da

Yapı

Hızlı Veriler

Formül: C14H11FN2OS
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.